Clinical Trial Update: Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of dendritic cell vaccine therapy with in situ maturation for pediatric brain tumors was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain Tumor
• Glioblastoma
• Glioma
• High-grade Glioma

Drugs mentioned

• Dendritic cell vaccine therapy with in situ maturation (dendritic cell vaccine)

Snippet

Sponsor: Edward Ziga | Conditions: Glioma, Brain Cancer | Phase 1 | Status: TERMINATED